{"version":"1.0","provider_name":"Biojam Holding Group","provider_url":"https:\/\/biojam.pt\/en","author_name":"eduardo","author_url":"https:\/\/biojam.pt\/en\/author\/eduardo\/","title":"Uma refer\u00eancia da Ind\u00fastria Farmac\u00eautica na Pen\u00ednsula Ib\u00e9rica - Biojam Holding Group","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"T3eYmm19JG\"><a href=\"https:\/\/biojam.pt\/en\/2021\/05\/14\/uma-referencia-da-industria-farmaceutica-na-peninsula-iberica\/\">A benchmark in the pharmaceutical industry on the Iberian Peninsula<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/biojam.pt\/en\/2021\/05\/14\/uma-referencia-da-industria-farmaceutica-na-peninsula-iberica\/embed\/#?secret=T3eYmm19JG\" width=\"600\" height=\"338\" title=\"&#8220;Uma refer\u00eancia da Ind\u00fastria Farmac\u00eautica na Pen\u00ednsula Ib\u00e9rica&#8221; &#8212; Biojam Holding Group\" data-secret=\"T3eYmm19JG\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/biojam.pt\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","thumbnail_url":"https:\/\/biojam.pt\/wp-content\/uploads\/2021\/05\/noticia-sol-carlos-monteiro-biojam-holding-group.jpg","thumbnail_width":790,"thumbnail_height":444,"description":"Noticia Sol A Biojam Holding Group, uma refer\u00eancia na Ind\u00fastria Farmac\u00eautica nacional e internacional, assume hoje um lugar de lideran\u00e7a no mercado ib\u00e9rico, onde foi pioneira no tratamento da Leucemia Linfobl\u00e1stica Aguda. Carlos Monteiro, CEO, deu-nos a conhecer um pouco melhor a g\u00e9nese deste projeto que \u00e9 hoje respons\u00e1vel pela distribui\u00e7\u00e3o do primeiro e \u00fanico..."}